Fedha

Hisa unazofuatilia
Kwa nini MVIR imeongezeka kwa 2.33%?
Fahamu zaidi
MVIR:STO
Medivir AB
SEK 1.49
+2.33%
(+0.034) Siku 1
9 Okt, 17:29:42 GMT +2  ·   SEK
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya MVIR...
Fungua
SEK 1.47
Juu
SEK 1.50
Chini
SEK 1.45
Mtaji wa soko
932.52M
Wastani wa kiasi cha mauzo
1.41M
Kiasi cha mauzo ya hisa
1.73M
Juu kwa wiki 52
SEK 2.88
Chini kwa wiki 52
SEK 0.34
EPS
-SEK 0.37
Hisa za wawekezaji
624.18M
Idadi ya wafanyakazi
6
Fungua
SEK 1.47
Juu
SEK 1.50
Chini
SEK 1.45
Mtaji wa soko
932.52M
Wastani wa kiasi cha mauzo
1.41M
Kiasi cha mauzo ya hisa
1.73M
Juu kwa wiki 52
SEK 2.88
Chini kwa wiki 52
SEK 0.34
EPS
-SEK 0.37
Hisa za wawekezaji
624.18M
Idadi ya wafanyakazi
6
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies. Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides. Medivir is listed on the Nasdaq Stockholm Mid Cap List. In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Kuhusu Medivir AB
Afisa Mkuu Mtendaji (CEO)Christine Lind
Wafanyakazi6
Lilianzishwa1988
Makao makuu-
Sekta-
Ripoti za awaliThamani zote katika SEK
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika SEK
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
1.00M
5.51M
1.10M
1.20M
Gharama ya bidhaa zilizouzwa
8.10M
10.21M
4.50M
17.90M
Gharama ya mapato
8.10M
10.21M
4.50M
17.90M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
5.80M
7.16M
5.50M
4.30M
Gharama ya uendeshaji
6.50M
37.66M
6.20M
4.50M
Jumla ya gharama za uendeshaji
14.60M
47.88M
10.70M
22.40M
Mapato ya uendeshaji
-13.60M
-42.37M
-9.60M
-21.20M
Mapato mengine yasiyo ya uendeshaji
-
elfu -500.00
elfu 200.00
-
EBT ikijumuisha vipengee visivyo vya kawaida
-14.60M
-43.20M
-9.40M
-20.10M
EBT bila kujumuisha vipengee visivyo vya kawaida
-14.60M
-43.77M
-9.40M
-20.10M
Gharama ya kodi ya mapato
-
-
-
-
Kiwango cha kodi kinachotumika
-
-
-
-
Gharama nyingine za uendeshaji
-
elfu -7.00
-
elfu 200.00
Mapato halisi
-14.60M
-43.20M
-9.40M
-20.10M
Kiwango cha faida halisi
-1,460.00%
-784.60%
-854.55%
-1,675.00%
Mapato kwa kila hisa
-0.13
-
-
-
Mapato ya riba na uwekezaji
-
elfu 41.00
-
1.10M
Gharama ya riba
-1.00M
-1.31M
-
-
Jumla ya gharama halisi za riba
-1.00M
-1.27M
-
1.10M
Gharama za kushuka kwa thamani na za kulipa deni
elfu 700.00
30.51M
elfu 700.00
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
-12.90M
-11.87M
-8.90M
-20.90M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google